FDA
approval
· 2025-09-10
FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
Summary
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) from Allergan, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)